Insuman Bazal suspension for injections 100 IU/ml. 3 ml. cartridge №5

Description

Insuman Bazal Composition
Active ingredient: human insulin;

1 ml of suspension contains 100 IU of human insulin (equivalent to 3.571 mg of human insulin);

Excipients: protamine sulfate, m cresol, phenol, zinc chloride, sodium phosphate dihydrate, glycerin (85%), sodium hydroxide, concentrated hydrochloric acid, water for injection.

Insuman Bazal Contraindications
Hypersensitivity to the drug Insuman Basal and any of its components, with the exception of cases of use as desensitizing therapy.

Insuman Bazal Mode of application
In clinical practice, many regimens for the treatment of human insulin are known. The choice of an individual scheme suitable for a particular patient should be made by the doctor, taking into account the need for insulin. Based on the established blood glucose concentration, the doctor determines the required dosage and type of insulin preparation for a particular patient. In type 2 diabetes, the average starting dose is 0.2 U / kg body weight.

Insuman Basal is intended for subcutaneous injection. In exceptional cases, it can be administered intramuscularly. Insuman Bazal should be administered 15-30 minutes before meals. Insulin should be removed from the refrigerator 10-20 minutes before the scheduled administration so that it warms up to room temperature.

Before the introduction, you should carefully examine the insulin vial or cartridge. Suspension Insuman Basal should be homogeneous opaque (homogeneous turbid or milky in appearance).

Particular care should be taken to ensure that the needle is not inserted into the lumen of the blood vessel during the injection of insulin.

Application features

Pregnant
Insulin does not cross the placental barrier. For patients who develop diabetes mellitus before pregnancy or during pregnancy (gestational diabetes), it is very important to maintain proper control of carbohydrate metabolism throughout pregnancy.

Children
There is not enough experience with the use of the drug in children.

Drivers
Patients should be informed about exactly what measures should be taken before driving to avoid exacerbations of hypoglycemia, in particular if early warning signs of hypoglycemia are absent or implicit, or if exacerbations of hypoglycemia occur frequently. Do not drive under these circumstances.

Overdose
With an overdose of insulin, symptoms of hypoglycemia appear, in particular, hunger, apathy, dizziness, muscle tremors, disorientation, anxiety, heart palpitations, increased sweating, vomiting, headache, confusion. With moderate hypoglycemia, it is sufficient to ingest a sweet liquid or food rich in carbohydrates. Rest is recommended. Patients should have sugar cubes, glucose or candy with them. It is not recommended to eat chocolate because the fat it contains delays the absorption of glucose.